Literature DB >> 28283095

Is it Sjögren's syndrome or burning mouth syndrome? Distinct pathoses with similar oral symptoms.

Hawra Aljanobi1, Amarpreet Sabharwal2, Bralavan Krishnakumar3, Jill M Kramer4.   

Abstract

Sjögren's syndrome (SS) and burning mouth syndrome (BMS) typically occur in postmenopausal women. Although these conditions have significantly different etiopathogeneses, patients with SS or BMS often present with analogous oral complaints. The similarities between the two conditions have led to considerable confusion on the part of medical and dental practitioners, and those with BMS or SS often wait years to receive a diagnosis. Therefore, it is imperative for clinicians to understand the characteristic subjective and objective features of each disease and how these can be used to distinguish them. This review will discuss the proposed etiology, clinical manifestations, histopathology, diagnostic criteria, and patient management of SS and BMS. We also identify key differences between the two pathoses that aid in establishing the correct diagnosis. Recognition of the defining features of each condition will lead to reduced time to diagnosis and improved patient management for these poorly understood conditions.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28283095      PMCID: PMC6025751          DOI: 10.1016/j.oooo.2017.01.005

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol


  175 in total

1.  Salivary gland and peripheral blood T helper 1 and 2 cell activity in Sjögren's syndrome compared with non-Sjögren's sicca syndrome.

Authors:  J M van Woerkom; A A Kruize; M J G Wenting-van Wijk; E Knol; I C Bihari; J W G Jacobs; J W J Bijlsma; F P J G Lafeber; J A G van Roon
Journal:  Ann Rheum Dis       Date:  2005-04-07       Impact factor: 19.103

2.  Caries clinical trial of a remineralising toothpaste in radiation patients.

Authors:  Athena Papas; David Russell; Mabi Singh; Ralph Kent; Cal Triol; Anthony Winston
Journal:  Gerodontology       Date:  2008-06       Impact factor: 2.980

3.  Associations between salivary gland histopathologic diagnoses and phenotypic features of Sjögren's syndrome among 1,726 registry participants.

Authors:  Troy E Daniels; Darren Cox; Caroline H Shiboski; Morten Schiødt; Ava Wu; Hector Lanfranchi; Hisanori Umehara; Yan Zhao; Stephen Challacombe; Mi Y Lam; Yvonne De Souza; Julie Schiødt; Helena Holm; Patricia A M Bisio; Mariana S Gandolfo; Toshioki Sawaki; Mengtao Li; Wen Zhang; Beni Varghese-Jacob; Per Ibsen; Alicia Keszler; Nozomu Kurose; Takayuki Nojima; Edward Odell; Lindsey A Criswell; Richard Jordan; John S Greenspan
Journal:  Arthritis Rheum       Date:  2011-07

Review 4.  Pathophysiology of primary burning mouth syndrome.

Authors:  Satu K Jääskeläinen
Journal:  Clin Neurophysiol       Date:  2011-10-24       Impact factor: 3.708

5.  Topical clonazepam in stomatodynia: a randomised placebo-controlled study.

Authors:  Christelle Gremeau-Richard; Alain Woda; Marie Louise Navez; Nadine Attal; Didier Bouhassira; Marie Claude Gagnieu; Jean François Laluque; Pascale Picard; Paul Pionchon; Stéphanie Tubert
Journal:  Pain       Date:  2004-03       Impact factor: 6.961

6.  Epithelial expression of vanilloid and cannabinoid receptors: a potential role in burning mouth syndrome pathogenesis.

Authors:  Elisa Borsani; Alessandra Majorana; Marco Angelo Cocchi; Giulio Conti; Sara Bonadeo; Alessandro Padovani; Giuseppe Lauria; Elena Bardellini; Rita Rezzani; Luigi Fabrizio Rodella
Journal:  Histol Histopathol       Date:  2013-11-05       Impact factor: 2.303

7.  Burning mouth syndrome (BMS): double blind controlled study of alpha-lipoic acid (thioctic acid) therapy.

Authors:  F Femiano; C Scully
Journal:  J Oral Pathol Med       Date:  2002-05       Impact factor: 4.253

8.  Immunological alterations in newly diagnosed primary Sjögren's syndrome characterized by skewed peripheral T-cell subsets and inflammatory cytokines.

Authors:  P Szodoray; I Gal; S Barath; M Aleksza; I F Horvath; P Gergely; G Szegedi; B Nakken; M Zeher
Journal:  Scand J Rheumatol       Date:  2008 May-Jun       Impact factor: 3.641

9.  Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome.

Authors:  Jacques-Eric Gottenberg; Nicolas Cagnard; Carlo Lucchesi; Franck Letourneur; Sylvie Mistou; Thierry Lazure; Sebastien Jacques; Nathalie Ba; Marc Ittah; Christine Lepajolec; Marc Labetoulle; Marc Ardizzone; Jean Sibilia; Catherine Fournier; Gilles Chiocchia; Xavier Mariette
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-13       Impact factor: 11.205

10.  Reduction in unstimulated salivary flow rate in burning mouth syndrome.

Authors:  R Poon; N Su; V Ching; M Darling; M Grushka
Journal:  Br Dent J       Date:  2014-10       Impact factor: 1.626

View more
  5 in total

1.  Sjogren's Syndrome and Pulmonary Disease.

Authors:  Ruben A Peredo; Scott Beegle
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Diagnostic performance of serology against histologic assessment to diagnose Sjogren's syndrome: a systematic review.

Authors:  Luiz Claudio Viegas-Costa; Reid Friesen; Carlos Flores-Mir; Timothy McGaw
Journal:  Clin Rheumatol       Date:  2021-06-17       Impact factor: 2.980

3.  Chemosensory dysfunction, Oral disorders and Oral health-related quality of life in patients with primary Sjögren's syndrome: comparative cross-sectional study.

Authors:  Mirjana Šijan Gobeljić; Vera Milić; Nada Pejnović; Nemanja Damjanov
Journal:  BMC Oral Health       Date:  2020-07-03       Impact factor: 2.757

Review 4.  Current and Emerging Evidence for Toll-Like Receptor Activation in Sjögren's Syndrome.

Authors:  Jeremy Kiripolsky; Jill M Kramer
Journal:  J Immunol Res       Date:  2018-12-20       Impact factor: 4.818

Review 5.  Smell and Taste Function and Their Disturbances in Sjögren's Syndrome.

Authors:  Katarzyna Błochowiak
Journal:  Int J Environ Res Public Health       Date:  2022-09-30       Impact factor: 4.614

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.